SCHEMBL26028707

SCHEMBL26028707

Clc1cc(N(c2cccc(N(c3ccccc3)c3cc(N(c4ccccc4)c4ccccc4)cc(N(c4ccccc4)c4ccccc4)c3)c2)c2c(-c3ccccc3)cccc2-c2ccccc2)cc(Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ TDP1 Q9NUW8 3/20 0.37
▸ CYP2A6 P11509 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP2C9 P11712 3/20 0.34
▸ CYP2C19 P33261 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ L3MBTL1 Q9Y468 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CRHR1 P34998 1/20 0.32
▸ MET P08581 2/20 0.31
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26033184 0.88 CYP1A2 (0.34) ALDH1A1TDP1LMNACYP1A2CYP2C9
SCHEMBL26028645 0.86 ALDH1A1 (0.47) ALDH1A1TDP1KDM4EHSP90AA1HSP90AB1
SCHEMBL13292383 0.84 BACE1 (0.38) ALDH1A1TDP1CYP2A6KDM4ECYP1A2
SCHEMBL26028713 0.84 ALDH1A1 (0.34) ALDH1A1TDP1KDM4ECYP1A2CYP2C9
SCHEMBL14556392 0.80 ALDH1A1 (0.52) ALDH1A1TDP1KDM4EHSP90AA1HSP90AB1
SCHEMBL25846931 0.80 MAPT (0.38) ALDH1A1TDP1CYP2A6L3MBTL1MEN1
SCHEMBL25846937 0.80 MAPT (0.40) CYP2A6MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL24624062 0.79 ALDH1A1 (0.36) ALDH1A1TDP1CYP2A6KDM4ELMNA
SCHEMBL30332614 0.79 ALDH1A1 (0.41) ALDH1A1TDP1CYP2A6KDM4ECYP1A2
SCHEMBL24623156 0.78 POLB (0.36) ALDH1A1TDP1CYP2A6KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263047-A1 LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263047-A1 LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT NR2E3, NFE2L2, CRY1 ALDH1A1 92/4885TDP1 2668/4885CYP2A6 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback